Metastatic pancreatic cancer is difficult to treat. Until recently, most patients would be offered treatment with a chemotherapy drug called gemcitabine. However, a large international trial showed th

NIAID Data Ecosystem30

Supplementary Table S4 from HMGA2 Expression Predicts Subtype, Survival, and Treatment Outcome in Pancreatic Ductal Adenocarcinoma

肿瘤生物标志物

癌症化疗方案

Supplementary Table S4. Chemotherapy Regimens.

Figshare2025-02-17 更新10

Implementation of contemporary chemotherapy for patients with metastatic pancreatic ductal adenocarcinoma: a population-based analysis

癌症化疗方案

临床评估

Background: Positive results of randomized trials led to the introduction of FOLFIRINOX in 2012 and gemcitabine with nab-paclitaxel in 2015 for patients with metastatic pancreatic ductal adenocarcinom

Figshare2020-02-14 更新40

Features of included agents and studies.

癌症化疗方案

非鳞状细胞癌治疗

N-S, non-squamous cell carcinoma; TC, paclitaxel+carboplatin; GP, gemcitabine+cisplatin; DOC, docetaxol; PEM, pemetrxed. Features of included agents and studies.

NIAID Data Ecosystem20